高级检索
当前位置: 首页 > 详情页

Dampening HOTAIR sensitizes the gastric cancer cells to oxaliplatin through miR-195-5p and ABCG2 pathway

文献详情

资源类型:
Pubmed体系:
机构: [1]Institute of Basic Medicine and Forensic Medicine, North Sichuan Medical College, Nanchong, China. [2]Department of Biochemistry and Molecular Biology, School of Basic Medicine and Forensic Medicine, North Sichuan Medical College, Nanchong, China. [3]School of Pharmacy, North Sichuan Medical College, Nanchong, China. [4]Department of Rehabilitation Medicine, the Affiliated Hospital of North Sichuan Medical College, Nanchong, China. [5]Department of Clinical Laboratory, the Affiliated Hospital of Jiaxing University, Jiaxing, China.
出处:
ISSN:

关键词: ABCG2 chemoresistance gastric cancer HOTAIR

摘要:
Long non-coding RNAs (lncRNA) have an extensive role in the progression and chemoresistance of gastric cancer (GC). Deeply study the regulatory role of lncRNAs could provide potential therapeutic targets. The aim of this study is to explore the regulatory role of HOTAIR in the progression and oxaliplatin resistance of GC. The expression of HOTAIR in GC and cell lines were detected by using qRT-PCR. Cell proliferation and apoptosis were analysed by CCK-8, EdU incorporation and flow cytometry. Luciferase reporter assay was used to identify the interaction between HOTAIR and ABCG2 (ATP-binding cassette (ABC) superfamily G member 2, ABCG2) via miR-195-5p. The regulatory functions were verified by using molecular biology experiments. HOTAIR was significantly overexpressed in GC and associated with poor prognosis. Knock-down of HOTAIR inhibited the GC cells proliferation and oxaliplatin resistance, while overexpression of HOTAIR showed opposite functions. Further studies found that HOTAIR acted as a competing endogenous RNA (ceRNA) to absorb miR-195-5p and elevated the expression of ABCG2, which leads to resistance of GC cells to oxaliplatin. Taken together, our findings demonstrated that HOTAIR regulates ABCG2 induced resistance of GC to oxaliplatin through miR-195-5p signalling and illustrate the great potential of developing new therapeutic targets for GC patients.© 2023 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 2 区 医学
小类 | 2 区 医学:研究与实验 3 区 细胞生物学
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 医学:研究与实验 3 区 细胞生物学
第一作者:
第一作者机构: [1]Institute of Basic Medicine and Forensic Medicine, North Sichuan Medical College, Nanchong, China. [2]Department of Biochemistry and Molecular Biology, School of Basic Medicine and Forensic Medicine, North Sichuan Medical College, Nanchong, China.
通讯作者:
通讯机构: [1]Institute of Basic Medicine and Forensic Medicine, North Sichuan Medical College, Nanchong, China. [2]Department of Biochemistry and Molecular Biology, School of Basic Medicine and Forensic Medicine, North Sichuan Medical College, Nanchong, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43378 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号